18691991

Source:http://linkedlifedata.com/resource/pubmed/id/18691991

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists.
Subject	Predicate	Object	Context
pubmed-article:18691991	rdf:type	pubmed:Citation	lld:pubmed
pubmed-article:18691991	lifeskim:mentions	umls-concept:C0030705	lld:lifeskim
pubmed-article:18691991	lifeskim:mentions	umls-concept:C0008976	lld:lifeskim
pubmed-article:18691991	lifeskim:mentions	umls-concept:C0037313	lld:lifeskim
pubmed-article:18691991	lifeskim:mentions	umls-concept:C0751249	lld:lifeskim
pubmed-article:18691991	lifeskim:mentions	umls-concept:C0242485	lld:lifeskim
pubmed-article:18691991	lifeskim:mentions	umls-concept:C0687676	lld:lifeskim
pubmed-article:18691991	lifeskim:mentions	umls-concept:C0205322	lld:lifeskim
pubmed-article:18691991	lifeskim:mentions	umls-concept:C0301630	lld:lifeskim
pubmed-article:18691991	lifeskim:mentions	umls-concept:C1696465	lld:lifeskim
pubmed-article:18691991	lifeskim:mentions	umls-concept:C0936012	lld:lifeskim
pubmed-article:18691991	lifeskim:mentions	umls-concept:C0079809	lld:lifeskim
pubmed-article:18691991	lifeskim:mentions	umls-concept:C1704243	lld:lifeskim
pubmed-article:18691991	lifeskim:mentions	umls-concept:C0439423	lld:lifeskim
pubmed-article:18691991	lifeskim:mentions	umls-concept:C1518681	lld:lifeskim
pubmed-article:18691991	lifeskim:mentions	umls-concept:C1617723	lld:lifeskim
pubmed-article:18691991	pubmed:issue	7	lld:pubmed
pubmed-article:18691991	pubmed:dateCreated	2008-8-11	lld:pubmed
pubmed-article:18691991	pubmed:abstractText	Ramelteon is a selective MT1/MT2 melatonin receptor agonist approved by the US Food and Drug Administration for insomnia treatment.	lld:pubmed
pubmed-article:18691991	pubmed:language	eng	lld:pubmed
pubmed-article:18691991	pubmed:journal	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:18691991	pubmed:citationSubset	IM	lld:pubmed
pubmed-article:18691991	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:18691991	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:18691991	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:18691991	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:18691991	pubmed:status	MEDLINE	lld:pubmed
pubmed-article:18691991	pubmed:month	Jul	lld:pubmed
pubmed-article:18691991	pubmed:issn	0149-2918	lld:pubmed
pubmed-article:18691991	pubmed:author	pubmed-author:JonesRoyR	lld:pubmed
pubmed-article:18691991	pubmed:author	pubmed-author:Wang-WeigandS...	lld:pubmed
pubmed-article:18691991	pubmed:author	pubmed-author:ZhangJeffJ	lld:pubmed
pubmed-article:18691991	pubmed:issnType	Print	lld:pubmed
pubmed-article:18691991	pubmed:volume	30	lld:pubmed
pubmed-article:18691991	pubmed:owner	NLM	lld:pubmed
pubmed-article:18691991	pubmed:authorsComplete	Y	lld:pubmed
pubmed-article:18691991	pubmed:pagination	1316-23	lld:pubmed
pubmed-article:18691991	pubmed:meshHeading	pubmed-meshheading:18691991...	lld:pubmed
pubmed-article:18691991	pubmed:meshHeading	pubmed-meshheading:18691991...	lld:pubmed
pubmed-article:18691991	pubmed:meshHeading	pubmed-meshheading:18691991...	lld:pubmed
pubmed-article:18691991	pubmed:meshHeading	pubmed-meshheading:18691991...	lld:pubmed
pubmed-article:18691991	pubmed:meshHeading	pubmed-meshheading:18691991...	lld:pubmed
pubmed-article:18691991	pubmed:meshHeading	pubmed-meshheading:18691991...	lld:pubmed
pubmed-article:18691991	pubmed:meshHeading	pubmed-meshheading:18691991...	lld:pubmed
pubmed-article:18691991	pubmed:meshHeading	pubmed-meshheading:18691991...	lld:pubmed
pubmed-article:18691991	pubmed:meshHeading	pubmed-meshheading:18691991...	lld:pubmed
pubmed-article:18691991	pubmed:meshHeading	pubmed-meshheading:18691991...	lld:pubmed
pubmed-article:18691991	pubmed:meshHeading	pubmed-meshheading:18691991...	lld:pubmed
pubmed-article:18691991	pubmed:meshHeading	pubmed-meshheading:18691991...	lld:pubmed
pubmed-article:18691991	pubmed:meshHeading	pubmed-meshheading:18691991...	lld:pubmed
pubmed-article:18691991	pubmed:year	2008	lld:pubmed
pubmed-article:18691991	pubmed:articleTitle	Ramelteon 8 mg/d versus placebo in patients with chronic insomnia: post hoc analysis of a 5-week trial using 50% or greater reduction in latency to persistent sleep as a measure of treatment effect.	lld:pubmed
pubmed-article:18691991	pubmed:affiliation	Takeda Pharmaceuticals North America, Inc., Deerfield, Illinois 60015, USA. lmini@tpna.com	lld:pubmed
pubmed-article:18691991	pubmed:publicationType	Journal Article	lld:pubmed
pubmed-article:18691991	pubmed:publicationType	Comparative Study	lld:pubmed
http://linkedlifedata.com/r...	pubmed:referesTo	pubmed-article:18691991	lld:pubmed